Altach Biomedical Recognized Among Spark Crowdfunding’s Top 100 Most Ambitious Companies
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ultrices tortor, vel lobortis nunc aliquet posuere…
At Altach our goal is to become the gold standard in regenerative cartilage technology. We are building a portfolio of biomimetic cartilage grafts allowing surgeons to repair cartilage defects and restore patient’s quality of life.

PROBLEM
Untreated, cartilage defects can lead to osteoarthritis which affects 1 in 4 adults. To prevent this over 600,000 cartilage repair procedures are performed annually in the US. Unfortunately, many of the currently available solutions do not provide satisfactory long-term outcomes, result in a low quality cartilage repair, require multiple procedures, or are prohibitively expensive.
TECHNOLOGY OVERVIEW
Altach is developing a portfolio of biomimetic cartilage scaffolds utilising Type II collagen which is the building block of native cartilage. The scaffolds are designed to be used stand alone and in conjunction with other cell based therapies. The implants unique composition create a matrix for the patient’s own cells to migrate into and regenerate the cartilage.

PATIENT IMPACT
Articular cartilage is a tissue which is critical for the pain and friction free movement of your joints. Our technology promotes the regeneration of damaged cartilage to allow patients to return to activity.
Untreated cartilage defects can lead to pain, inflammation and osteoarthritis. Our scaffold regenerates damaged cartilage and bone in order to reduce pain and delay or stop progression of cartilage damage to osteoarthritis
The unique characteristics of the Altach technology promote true tissue regeneration rather than temporary repair, providing patients with improved outcomes.

Altach’s biomimetic scaffold closely mimic natural cartilage, providing surgeons with advanced tools to perform more precise and effective repairs.
Our scaffold are designed for ease of integration, reducing complexity in the operating room and enabling faster, more reliable procedures.
By using innovative regenerative solutions, surgeons can offer their patients improved long-term joint function and reduced recovery times, leading to higher satisfaction and success rates.
ABOUT US
Altach is a spinout from Trinity College Dublin and is part of NLC, a leading worldwide health venture builder.

CEO

Inventor

Chief Technology Officer

Inventor

NLC Venture Partner
LATEST NEWS